echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Medical News > Medical Research Articles > China's domestic new crown treatment drugs make new progress

    China's domestic new crown treatment drugs make new progress

    • Last Update: 2022-09-07
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com
    According to Chinese official media news: The reporter recently learned from the scientific research team of the Joint Prevention and Control Mechanism of the State Council that China is actively promoting the research and development of new crown treatment drugs.
    In addition to the approved neutralizing antibodies, chemical drugs and traditional Chinese medicines, there are many drugs in clinical trials.
    It has shown curative effect, and technological innovation has effectively contributed to the prevention and control of the epidemic
    .
     
    In December 2021, the State Food and Drug Administration urgently approved the registration applications of the new coronavirus neutralizing antibody combination therapy drug Ambavirumab injection (BRII-196) and romisevirumab injection (BRII-198)
    .
    This is China's first approved novel coronavirus neutralizing antibody combination therapy drug with independent intellectual property rights
    .
     
    In July 2022, the State Food and Drug Administration approved the registration application for Azvudine Tablets to increase the indication for the treatment of new coronary pneumonia
    .
    This is an oral small molecule new coronary pneumonia treatment drug independently developed by China
    .
     
    Previously, in the anti-epidemic struggle in Wuhan, Hubei, relevant academicians and experts led a team of scientific researchers.
    In view of the situation that no specific drugs were available in the early stage, and guided by the need for treatment, a batch of drugs such as the "three medicines and three prescriptions" of traditional Chinese medicine were screened out for the new coronary pneumonia.
    Rescue provides a strong guarantee
    .
     
    Liu Dengfeng, Inspector of the Department of Science and Education of the National Health Commission , introduced that after the outbreak of the new crown epidemic, the joint prevention and control mechanism of the State Council immediately organized drug research and development.
    A lot of work has been done on such aspects
    .
    Platforms and teams based on the accumulation of drug screening, vaccine research and development, and clinical evaluation based on the major national new drug creation projects have quickly promoted the successful launch of neutralizing antibodies, chemical drugs and traditional Chinese medicines
    .
     
    It is understood that there are still a number of new crown treatment drugs in different stages of research and development in China, and some drugs have already launched phase III clinical trials at home and abroad
    .
     
    According to the relevant person in charge of the scientific research team of the Joint Prevention and Control Mechanism of the State Council, the current research and development of new crown treatment drugs mainly focuses on three technical routes: blocking virus entry into cells, inhibiting virus replication, and regulating the human immune system.
    China has deployed these technical routes
    .
     
    The State Council's Joint Prevention and Control Mechanism Scientific Research Team, whichis composed of the Ministry of Science and Technology, the National Health and Health Commission, the Ministry of Industry and Information Technology, the National Development and Reform Commission, the State Food and Drug Administration, and the State Administration of Traditional Chinese Medicine , is a special class for drug research and development since February 2020.
    Since its establishment on March 16, it has organized a national team of outstanding experts to fully promote the research and development of effective drugs and treatment technologies
    .
    (Finish)
    According to Chinese official media news: The reporter recently learned from the scientific research team of the Joint Prevention and Control Mechanism of the State Council that China is actively promoting the research and development of new crown treatment drugs.
    In addition to the approved neutralizing antibodies, chemical drugs and traditional Chinese medicines, there are many drugs in clinical trials.
    It has shown curative effect, and technological innovation has effectively contributed to the prevention and control of the epidemic
    .
     
    In December 2021, the State Food and Drug Administration urgently approved the registration applications of the new coronavirus neutralizing antibody combination therapy drug Ambavirumab injection (BRII-196) and romisevirumab injection (BRII-198)
    .
    This is China's first approved novel coronavirus neutralizing antibody combination therapy drug with independent intellectual property rights
    .
     
      In July 2022, the State Food and Drug Administration approved the registration application for Azvudine Tablets to increase the indication for the treatment of new coronary pneumonia
    .
    This is an oral small molecule new coronary pneumonia treatment drug independently developed by China
    .
     
      Previously, in the anti-epidemic struggle in Wuhan, Hubei, relevant academicians and experts led a team of scientific researchers.
    In view of the situation that no specific drugs were available in the early stage, and guided by the need for treatment, a batch of drugs such as the "three medicines and three prescriptions" of traditional Chinese medicine were screened out for the new coronary pneumonia.
    Rescue provides a strong guarantee
    .
     
      Liu Dengfeng, Inspector of the Department of Science and Education of the National Health Commission , introduced that after the outbreak of the new crown epidemic, the joint prevention and control mechanism of the State Council immediately organized drug research and development.
    A lot of work has been done on such aspects
    .
    Platforms and teams based on the accumulation of drug screening, vaccine research and development, and clinical evaluation based on the major national new drug creation projects have quickly promoted the successful launch of neutralizing antibodies, chemical drugs and traditional Chinese medicines
    .
    healthy and healthy
     
      It is understood that there are still a number of new crown treatment drugs in different stages of research and development in China, and some drugs have already launched phase III clinical trials at home and abroad
    .
     
      According to the relevant person in charge of the scientific research team of the Joint Prevention and Control Mechanism of the State Council, the current research and development of new crown treatment drugs mainly focuses on three technical routes: blocking virus entry into cells, inhibiting virus replication, and regulating the human immune system.
    China has deployed these technical routes
    .
     
    The State Council's Joint Prevention and Control Mechanism Scientific Research Team, which   is composed of the Ministry of Science and Technology, the National Health and Health Commission, the Ministry of Industry and Information Technology, the National Development and Reform Commission, the State Food and Drug Administration, and the State Administration of Traditional Chinese Medicine , is a special class for drug research and development since February 2020.
    Since its establishment on March 16, it has organized a national team of outstanding experts to fully promote the research and development of effective drugs and treatment technologies
    .
    (Finish)
    Medicine and medicine
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.